BACKGROUND: There are limited data available on tumour subtype-specific familial risks for nervous-system tumours. We aimed to provide such data at the population level. METHODS: We used data from the nationwide Swedish and Norwegian databases on familial cancer to calculate standardised incidence ratios (SIRs) for the familial risk of developing a nervous-system tumour in offspring born after 1931 (Sweden) or 1900 (Norway) whose parents or siblings were probands. FINDINGS: 54 195 patients had nervous-system tumours, 22 331 of whom belonged to the offspring generation aged 0-72 years in Sweden and 0-51 years in Norway. Of 709 familial patients in the offspring generation, 438 (61.8%) had a parent affected by a nervous-system tumour (SIR 1.66; 95% CI 1.51-1.82), 236 (33.3%) had a sibling affected by a nervous-system tumour (SIR 2.01; 95% CI 1.76-2.28), and 35 (4.9%) belonged to families with a parent and at least two siblings affected by a nervous-system tumour (multiplex families; SIR 13.40; 95% CI 9.33-18.66). The SIR for glioma was 1.8 (1.5-2.0) when a parent was a proband, but increased to 11.2 (5.7-19.5) in multiplex families. Early-onset neurinoma and haemangioma showed high familial risks; with an SIR for neurinoma of 1.7 (1.4-2.2) for offspring of affected parents, 2.7 (2.0-3.5) for siblings, and 27.2 (13.5-48.8) for multiplex families, and an SIR for haemangioma of 2.4 (1.4-3.8) for offspring of affected parents. Histology-specific population-based familial risks were shown for meningioma (1.6 for offspring of affected parents; 95% CI 1.3-2.0), ependymoma (2.7 for young offspring <20 years; 1.1-5.5), medulloblastoma (4.1 for siblings; 1.7-8.1), and neuroblastoma (3.2 for siblings; 1.1-6.9). INTERPRETATION: Our results suggest a complex genetic background for nervous-system tumours, which differs depending on the age of onset and histological subtype of the tumour. High sibling risks might suggest recessive inheritance. As the high-penetrant multiplex families only accounted for about 5% of familial nervous-system tumours, most familial cases are probably caused by low-penetrance genes. FUNDING: The Nordic Cancer Union, Deutsche Krebshilfe, the Swedish Cancer Society, and the Swedish Council for Working Life and Social Research.
BACKGROUND: There are limited data available on tumour subtype-specific familial risks for nervous-system tumours. We aimed to provide such data at the population level. METHODS: We used data from the nationwide Swedish and Norwegian databases on familial cancer to calculate standardised incidence ratios (SIRs) for the familial risk of developing a nervous-system tumour in offspring born after 1931 (Sweden) or 1900 (Norway) whose parents or siblings were probands. FINDINGS: 54 195 patients had nervous-system tumours, 22 331 of whom belonged to the offspring generation aged 0-72 years in Sweden and 0-51 years in Norway. Of 709 familial patients in the offspring generation, 438 (61.8%) had a parent affected by a nervous-system tumour (SIR 1.66; 95% CI 1.51-1.82), 236 (33.3%) had a sibling affected by a nervous-system tumour (SIR 2.01; 95% CI 1.76-2.28), and 35 (4.9%) belonged to families with a parent and at least two siblings affected by a nervous-system tumour (multiplex families; SIR 13.40; 95% CI 9.33-18.66). The SIR for glioma was 1.8 (1.5-2.0) when a parent was a proband, but increased to 11.2 (5.7-19.5) in multiplex families. Early-onset neurinoma and haemangioma showed high familial risks; with an SIR for neurinoma of 1.7 (1.4-2.2) for offspring of affected parents, 2.7 (2.0-3.5) for siblings, and 27.2 (13.5-48.8) for multiplex families, and an SIR for haemangioma of 2.4 (1.4-3.8) for offspring of affected parents. Histology-specific population-based familial risks were shown for meningioma (1.6 for offspring of affected parents; 95% CI 1.3-2.0), ependymoma (2.7 for young offspring <20 years; 1.1-5.5), medulloblastoma (4.1 for siblings; 1.7-8.1), and neuroblastoma (3.2 for siblings; 1.1-6.9). INTERPRETATION: Our results suggest a complex genetic background for nervous-system tumours, which differs depending on the age of onset and histological subtype of the tumour. High sibling risks might suggest recessive inheritance. As the high-penetrant multiplex families only accounted for about 5% of familial nervous-system tumours, most familial cases are probably caused by low-penetrance genes. FUNDING: The Nordic Cancer Union, Deutsche Krebshilfe, the Swedish Cancer Society, and the Swedish Council for Working Life and Social Research.
Authors: Lindsay B Robertson; Georgina N Armstrong; Bianca D Olver; Amy L Lloyd; Sanjay Shete; Ching Lau; Elizabeth B Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Joellen Schildkraut; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Ping Yang; Amanda Lynn Rynearson; Amanda L Rynerason; Margaret Wrensch; Lucie McCoy; John K Wienkce; Bridget McCarthy; Faith Davis; Nicholas A Vick; Christoffer Johansen; Hanne Bødtcher; Siegal Sadetzki; Revital Bar-Sade Bruchim; Galit Hirsh Yechezkel; Ulrika Andersson; Beatrice S Melin; Melissa L Bondy; Richard S Houlston Journal: Fam Cancer Date: 2010-09 Impact factor: 2.375
Authors: Zhaoming Wang; Preetha Rajaraman; Beatrice S Melin; Charles C Chung; Weijia Zhang; Roberta McKean-Cowdin; Dominique Michaud; Meredith Yeager; Anders Ahlbom; Demetrius Albanes; Ulrika Andersson; Laura E Beane Freeman; Julie E Buring; Mary Ann Butler; Tania Carreón; Maria Feychting; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Goran Hallmans; Roger Henriksson; Judith Hoffman-Bolton; Peter D Inskip; Cari M Kitahara; Loic Le Marchand; Martha S Linet; Shengchao Li; Ulrike Peters; Mark P Purdue; Nathaniel Rothman; Avima M Ruder; Howard D Sesso; Gianluca Severi; Meir Stampfer; Victoria L Stevens; Kala Visvanathan; Sophia S Wang; Emily White; Anne Zeleniuch-Jacquotte; Robert Hoover; Joseph F Fraumeni; Nilanjan Chatterjee; Patricia Hartge; Stephen J Chanock Journal: Hum Mutat Date: 2015-05-18 Impact factor: 4.878
Authors: Victor Enciso-Mora; Fay J Hosking; Ben Kinnersley; Yufei Wang; Sanjay Shete; Diana Zelenika; Peter Broderick; Ahmed Idbaih; Jean-Yves Delattre; Khe Hoang-Xuan; Yannick Marie; Anna Luisa Di Stefano; Marianne Labussière; Sara Dobbins; Blandine Boisselier; Pietro Ciccarino; Marta Rossetto; Georgina Armstrong; Yanhong Liu; Konstantinos Gousias; Johannes Schramm; Ching Lau; Sarah J Hepworth; Konstantin Strauch; Martina Müller-Nurasyid; Stefan Schreiber; Andre Franke; Susanne Moebus; Lewin Eisele; Asta Forsti; Kari Hemminki; Ian P Tomlinson; Anthony Swerdlow; Mark Lathrop; Matthias Simon; Melissa Bondy; Marc Sanson; Richard S Houlston Journal: Hum Mol Genet Date: 2013-02-11 Impact factor: 6.150
Authors: Jon Foss-Skiftesvik; Christian Munch Hagen; René Mathiasen; Dea Adamsen; Marie Bækvad-Hansen; Anders D Børglum; Merete Nordentoft; Thomas Werge; Michael Christiansen; Kjeld Schmiegelow; Marianne Juhler; Preben Bo Mortensen; David Michael Hougaard; Jonas Bybjerg-Grauholm Journal: Childs Nerv Syst Date: 2020-11-23 Impact factor: 1.475
Authors: Sanjay Shete; Ching C Lau; Richard S Houlston; Elizabeth B Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Joellen Schildkraut; Siegal Sadetzki; Christoffer Johansen; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Ping Yang; Nicholas A Vick; Margaret Wrensch; Faith G Davis; Bridget J McCarthy; Eastwood Hon-chiu Leung; Caleb Davis; Rita Cheng; Fay J Hosking; Georgina N Armstrong; Yanhong Liu; Robert K Yu; Roger Henriksson; Beatrice S Melin; Melissa L Bondy Journal: Cancer Res Date: 2011-10-28 Impact factor: 12.701
Authors: K Hemminki; S Tretli; J H Olsen; L Tryggvadottir; E Pukkala; J Sundquist; C Granström Journal: Br J Cancer Date: 2010-05-25 Impact factor: 7.640
Authors: Preetha Rajaraman; Beatrice S Melin; Zhaoming Wang; Roberta McKean-Cowdin; Dominique S Michaud; Sophia S Wang; Melissa Bondy; Richard Houlston; Robert B Jenkins; Margaret Wrensch; Meredith Yeager; Anders Ahlbom; Demetrius Albanes; Ulrika Andersson; Laura E Beane Freeman; Julie E Buring; Mary Ann Butler; Melissa Braganza; Tania Carreon; Maria Feychting; Sarah J Fleming; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Goran Hallmans; Roger Henriksson; Judith Hoffman-Bolton; Peter D Inskip; Christoffer Johansen; Cari M Kitahara; Mark Lathrop; Chenwei Liu; Loic Le Marchand; Martha S Linet; Stefan Lonn; Ulrike Peters; Mark P Purdue; Nathaniel Rothman; Avima M Ruder; Marc Sanson; Howard D Sesso; Gianluca Severi; Xiao-Ou Shu; Matthias Simon; Meir Stampfer; Victoria L Stevens; Kala Visvanathan; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Paul Decker; Victor Enciso-Mora; Brooke Fridley; Yu-Tang Gao; Matthew Kosel; Daniel H Lachance; Ching Lau; Terri Rice; Anthony Swerdlow; Joseph L Wiemels; John K Wiencke; Sanjay Shete; Yong-Bing Xiang; Yuanyuan Xiao; Robert N Hoover; Joseph F Fraumeni; Nilanjan Chatterjee; Patricia Hartge; Stephen J Chanock Journal: Hum Genet Date: 2012-08-11 Impact factor: 4.132